HCPLive

Ulcerative Colitis 
The MD Magazine Ulcerative Colitis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Patients with Crohn's Disease Treated with Filgotinib Experienced Higher Rates of Clinical Remission and Improved Quality of Life Compared to Patients Who Received Placebo
Filgotinib is the first oral, JAK1-selective inhibitor showing efficacy in moderate-to-severe Crohn's disease patients.
Risankizumab is a humanized monoclonal antibody that selectively inhibits IL-23 through specific targeting of the IL-23 p19 subunit.
Patients can control and reduce their risk for contracting colon cancer and colitis by maintaining a balance of two major isoforms, according to findings published in the journal eLife.
Mothers’ inflammatory bowel disease (IBD) therapies may impact their newborns, according to findings published in Gastroenterology.
The development of new medications for any condition requires attention to detail in a number of areas, especially safety and efficacy. A recent drug developed for irritable bowel syndrome (IBS) looked to be effective in both areas prior to its approval.
The new Rome IV criteria classify the functional bowel disorders into five distinct categories, including irritable bowel syndrome (IBS), functional constipation, functional diarrhea, functional abdominal bloating/distention, and unspecified functional bowel disorder. A new category for opioid-induced constipation, which is distinct from the functional bowel disorders, has been added.
Rome IV updates include more specific definitions and diagnostic criteria for functional gastroduodenal disorders such as functional dyspepsia, belching disorders, and nausea and vomiting disorders.
The Rome Foundation announced the release of updated and revised Rome IV diagnostic criteria for more than 20 different gastrointestinal disorders at DDW 2016.
Endoscopic retrograde cholangiopancreatography is a common procedure in adult patients but a recent study looked at whether the procedure was safe for younger patients and whether it provided the same level of efficacy.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$